Literature DB >> 27878345

Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic.

Marco Krasselt1, Jean-Philipp Ivanov2, Christoph Baerwald2, Olga Seifert2.   

Abstract

Patients with rheumatoid arthritis (RA) are at an increased risk of acquiring infections due to two reasons: the disease itself and the immunosuppressive therapy. Vaccinations against preventable diseases are therefore of utmost importance for these group of patients. To estimate vaccination frequencies among patients with rheumatoid arthritis, we studied patients in a survey and calculated vaccination rates based on their vaccination documents. Patients have been recruited from our outpatient clinic during one of their routine visits. For the statistical analysis, they have been divided by age (≥60 vs <60 years) and medication (DMARD, Biologics, TNF inhibitors) for further subgroup analysis. Among the studied patients (n = 331), we found rather low vaccination rates, in particular for the strongly recommended vaccines against Pneumococcus and Influenza (33 and 53%, respectively). Furthermore, protection rates for important basic vaccinations, e.g. against Pertussis, were found to be very low with 12% only. Beside these findings, we saw age-dependent differences for a variety of vaccines: while Pneumococcus and Influenza vaccines were more often given to patients ≥60 years, MMR, Pertussis, Diphtheria and Hepatitis were significantly more often applied to younger patients. Vaccination rates have to be improved among RA patients, in particular for vaccines protecting from respiratory tract infections such as Pneumococcus.

Entities:  

Keywords:  Anti-TNF therapy; DMARDs; Immunosenescence; Pneumococcus; Rheumatoid arthritis; Vaccination rates; Vaccinations

Mesh:

Substances:

Year:  2016        PMID: 27878345     DOI: 10.1007/s00296-016-3608-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

Review 2.  Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Charlotte Hua; Thomas Barnetche; Bernard Combe; Jacques Morel
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-07       Impact factor: 4.794

Review 3.  The aging immune system: primer and prospectus.

Authors:  R A Miller
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

Review 4.  Aging of the innate immune system.

Authors:  Albert C Shaw; Samit Joshi; Hannah Greenwood; Alexander Panda; Janet M Lord
Journal:  Curr Opin Immunol       Date:  2010-08       Impact factor: 7.486

5.  Perturbation of the T cell repertoire in rheumatoid arthritis.

Authors:  U G Wagner; K Koetz; C M Weyand; J J Goronzy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; Nadia Gunraj; J Carter Thorne; Janet Pope; Alfred Cividino; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

7.  [Vaccination in adult patients with chronic inflammatory rheumatic diseases].

Authors:  S Goldacker; A M Gause; K Warnatz
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

8.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01

9.  CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence.

Authors:  Marco Krasselt; Christoph Baerwald; Ulf Wagner; Manuela Rossol
Journal:  Arthritis Res Ther       Date:  2013-10-01       Impact factor: 5.156

10.  Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.

Authors:  Ruth Costello; Kevin L Winthrop; Stephen R Pye; Benjamin Brown; William G Dixon
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more
  15 in total

1.  Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic.

Authors:  M Krasselt; C Baerwald; O Seifert
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

Review 2.  Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review.

Authors:  Vincent Gosselin Boucher; Sandra Pelaez; Claudia Gemme; Sara Labbe; Kim L Lavoie
Journal:  Clin Rheumatol       Date:  2020-07-03       Impact factor: 2.980

3.  Uptake and Attitudes About Immunizations in People With Multiple Sclerosis.

Authors:  Ruth Ann Marrie; Leanne Kosowan; Gary R Cutter; Robert Fox; Amber Salter
Journal:  Neurol Clin Pract       Date:  2021-08

4.  Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects.

Authors:  Caitlyn L Holmes; Chloe G Peyton; Amy M Bier; Tobias Z Donlon; Fauzia Osman; Christie M Bartels; Miriam A Shelef
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

5.  Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.

Authors:  Niklas Schmedt; Julia Schiffner-Rohe; Ralf Sprenger; Jochen Walker; Christof von Eiff; Dennis Häckl
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

6.  Low Influenza, Pneumococcal and Diphtheria-Tetanus-Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren's Syndrome: A Cross-Sectional Study.

Authors:  Jacques Morel; Hind Letaief; Philippe Guilpain; Xavier Mariette; Bernard Combe; Cédric Lukas
Journal:  Vaccines (Basel)       Date:  2019-12-21

7.  Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study.

Authors:  Ruth Ann Marrie; Randy Walld; James M Bolton; Jitender Sareen; Scott B Patten; Alexander Singer; Lisa M Lix; Carol A Hitchon; James J Marriott; Renée El-Gabalawy; Alan Katz; John D Fisk; Charles N Bernstein
Journal:  CMAJ Open       Date:  2021-05-14

8.  Mortality of Sepsis in Patients With Rheumatoid Arthritis: A Single-Center Retrospective Analysis and Comparison With a Control Group.

Authors:  Marco Krasselt; Christoph Baerwald; Sirak Petros; Olga Seifert
Journal:  J Intensive Care Med       Date:  2020-04-06       Impact factor: 3.510

9.  Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.

Authors:  Hussain Abdulrahman Al-Omar; Hadeel Magdy Sherif; Ahmed Yaccob Mayet
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

10.  [How well are patients with inflammatory rheumatic diseases protected against measles?]

Authors:  U Kiltz; A Celik; S Tsiami; X Baraliakos; I Andreica; D Kiefer; B Bühring; J Braun
Journal:  Z Rheumatol       Date:  2020-09-15       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.